Literature DB >> 10548600

Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.

B C Fauser1, P Devroey, S S Yen, R Gosden, W F Crowley, D T Baird, P Bouchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10548600     DOI： 10.1093/humrep/14.11.2681

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  19 in total

1.  Pregnancy and birth after GnRH agonist treatment for induction of final oocyte maturation in a woman undergoing ovarian stimulation for ICSI, using a GnRH antagonist (Orgalutran/Antagon) to prevent a premature LH surge: a case report.

Authors:  D De Jong; E G Van Hooren; N S Macklon; B M Mannaerts; B C Fauser
Journal:  J Assist Reprod Genet       Date:  2001-01       Impact factor: 3.412

2.  The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort?

Authors:  D de Jong; M J C Eijkemans; N G M Beckers; R V Pruijsten; B C J M Fauser; N S Macklon
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

3.  Embryo wastage rates remain high in assisted reproductive technology (ART): a look at the trends from 2004-2013 in the USA.

Authors:  Sanaz Ghazal; Pasquale Patrizio
Journal:  J Assist Reprod Genet       Date:  2016-12-27       Impact factor: 3.412

4.  Egg sharing in return for subsidized fertility treatment--ethical challenges and pitfalls.

Authors:  Boon Chin Heng
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

5.  Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF).

Authors:  D J Hendriks; E R Klinkert; L F J M M Bancsi; C W N Looman; J D F Habbema; E R te Velde; F J Broekmans
Journal:  J Assist Reprod Genet       Date:  2004-03       Impact factor: 3.412

Review 6.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

Review 7.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?

Authors:  Georg Griesinger; Ricardo E Felberbaum; Askan Schultze-Mosgau; Klaus Diedrich
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Affordable ART for developing countries: a cost benefit comparison of low dose stimulation versus high dose GnRH antagonist protocol.

Authors:  M Noorashikin; F B Ong; M H Omar; M R Zainul-Rashid; A Z Murad; A Shamsir; M A Norsina; A Nurshaireen; N S M N Sharifah-Teh; A H Fazilah
Journal:  J Assist Reprod Genet       Date:  2008-07-25       Impact factor: 3.412

10.  Ageing and ovarian stimulation modulate the relative levels of transcript abundance of oocyte DNA repair genes during the germinal vesicle-metaphase II transition in mice.

Authors:  Fabrizzio Horta; Aravind Ravichandran; Sally Catt; Beverley Vollenhoven; Peter Temple-Smith
Journal:  J Assist Reprod Genet       Date:  2020-10-17       Impact factor: 3.412
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.